The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases
| dc.contributor.author | Zilli, Thomas | |
| dc.contributor.author | Dirix, Piet | |
| dc.contributor.author | Heikkilä, Reino | |
| dc.contributor.author | Liefhooghe, Nick | |
| dc.contributor.author | Siva, Shankar | |
| dc.contributor.author | Gómez Iturriaga, Alfonso | |
| dc.contributor.author | Everaerts, Wouter | |
| dc.contributor.author | Otte, François Xavier | |
| dc.contributor.author | Couñago Lorenzo, Felipe | |
| dc.contributor.author | Ost, Piet | |
| dc.contributor.author | Et al. | |
| dc.date.accessioned | 2023-07-31T18:32:47Z | |
| dc.date.available | 2023-07-31T18:32:47Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | Optimal local treatment for nodal oligorecurrent prostate cancer is unknown. The randomized phase 2 PEACE V-STORM trial will explore the best treatment approach in this setting. Early results on the acute toxicity profile are projected to be published in quarter 3, 2021. | spa |
| dc.description.filiation | UEM | spa |
| dc.description.impact | 5.952 Q1 JCR 2021 | spa |
| dc.description.impact | 1.453 Q1 SJR 2021 | spa |
| dc.description.impact | No data IDR 2021 | spa |
| dc.description.sponsorship | Sin financiación | spa |
| dc.identifier.citation | Zilli, T., Dirix, P., Heikkilä, R., Liefhooghe, N., Siva, S., Gómez-Iturriaga, A., Everaerts, W., Otte, F., Shelan, M., Mercier, C., Achard, V., Thon, K., Stellamans, K., Moon, D., Conde-Moreno, A., Papachristofilou, A., Scorsetti, M., Gückenberger, M., Ameye, F., Zapatero, A., … Ost, P. (2021). The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases. European Urology Focus, 7(2), 241–244. https://doi.org/10.1016/j.euf.2020.12.010 | spa |
| dc.identifier.doi | 10.1016/j.euf.2020.12.010 | |
| dc.identifier.issn | 2405-4569 | |
| dc.identifier.uri | http://hdl.handle.net/11268/12251 | |
| dc.language.iso | eng | spa |
| dc.peerreviewed | Si | spa |
| dc.relation.publisherversion | https://doi.org/10.1016/j.euf.2020.12.010 | spa |
| dc.rights.accessRights | restricted access | spa |
| dc.subject.other | Neoplasias de la próstata | spa |
| dc.subject.other | Terapia recuperativa | spa |
| dc.subject.unesco | Cáncer | spa |
| dc.subject.unesco | Actividad científica | spa |
| dc.subject.unesco | Tratamiento médico | spa |
| dc.title | The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases | spa |
| dc.type | journal article | spa |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | 2e374c15-a9f7-4137-99a8-6be419e2c462 | |
| relation.isAuthorOfPublication.latestForDiscovery | 2e374c15-a9f7-4137-99a8-6be419e2c462 |

